Skip to main content
Top
Published in: Health Research Policy and Systems 1/2018

Open Access 01-12-2018 | Research

A longitudinal review of national HIV policy and progress made in health facility implementation in Eastern Zimbabwe

Authors: Malebogo Tlhajoane, Tidings Masoka, Edith Mpandaguta, Rebecca Rhead, Kathryn Church, Alison Wringe, Noah Kadzura, Nimalan Arinaminpathy, Constance Nyamukapa, Nadine Schur, Owen Mugurungi, Morten Skovdal, Jeffrey W. Eaton, Simon Gregson

Published in: Health Research Policy and Systems | Issue 1/2018

Login to get access

Abstract

Background

In recent years, WHO has made major changes to its guidance on the provision of HIV care and treatment services. We conducted a longitudinal study from 2013 to 2015 to establish how these changes have been translated into national policy in Zimbabwe and to measure progress in implementation within local health facilities.

Methods

National HIV programme policy guidelines published between 2003 and 2013 (n = 9) and 2014 and 2015 (n = 5) were reviewed to assess adoption of WHO recommendations on HIV testing services, prevention of mother-to-child transmission (PMTCT) of HIV, and provision of antiretroviral therapy (ART). Changes in local implementation of these policies over time were measured in two rounds of a survey conducted at 36 health facilities in Eastern Zimbabwe in 2013 and 2015.

Results

High levels of adoption of WHO guidance into national policy were recorded, including adoption of new recommendations made in 2013–2015 to introduce PMTCT Option B+ and to increase the threshold for ART initiation from CD4 ≤ 350 cells/mm3 to ≤ 500 cells/mm3. New strategies to implement national HIV policies were introduced such as the decentralisation of ART services from hospitals to clinics and task-shifting of care from doctors to nurses. The proportions of health facilities offering free HIV testing and counselling, PMTCT (including Option B+) and ART services increased substantially from 2013 to 2015, despite reductions in numbers of health workers. Provision of provider-initiated HIV testing remained consistently high. At least one test-kit stock-out in the prior year was reported in most facilities (2013: 69%; 2015: 61%; p = 0.44). Stock-outs of first-line ART and prophylactic drugs for opportunistic infections remained low. Repeat testing for HIV-negative individuals within 3 months decreased (2013: 97%; 2015: 72%; p = 0.01). Laboratory testing remained low across both survey rounds, despite policy and operational guidelines to expand coverage of diagnostic services.

Conclusions

Good progress has been made in implementing international guidance on HIV service delivery in Zimbabwe. Further novel implementation strategies may be needed to achieve the latest targets for universal ART eligibility.
Literature
1.
go back to reference UNAIDS, The Joint United Nations Programme on HIV/AIDS. AIDS by the Numbers. Geneva: UNAIDS; 2016. UNAIDS, The Joint United Nations Programme on HIV/AIDS. AIDS by the Numbers. Geneva: UNAIDS; 2016.
2.
go back to reference Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339(6122):966–71.CrossRef Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339(6122):966–71.CrossRef
3.
go back to reference Vandormael A, Newell M-L, Bärnighausen T, Tanser F. Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004–12: a prospective cohort study. Lancet Glob Health. 2014;2(4):e209–e15.CrossRef Vandormael A, Newell M-L, Bärnighausen T, Tanser F. Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004–12: a prospective cohort study. Lancet Glob Health. 2014;2(4):e209–e15.CrossRef
4.
go back to reference Jahn A, Floyd S, Crampin AC, Mwaungulu F, Mvula H, Munthali F, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet. 2008;371(9624):1603–11.CrossRef Jahn A, Floyd S, Crampin AC, Mwaungulu F, Mvula H, Munthali F, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet. 2008;371(9624):1603–11.CrossRef
5.
go back to reference Herout S, Mandorfer M, Breitenecker F, Reiberger T, Grabmeier-Pfistershammer K, Rieger A, et al. Impact of early initiation of antiretroviral therapy in patients with acute HIV infection in Vienna, Austria. PLoS One. 2016;11(4):e0152910.CrossRef Herout S, Mandorfer M, Breitenecker F, Reiberger T, Grabmeier-Pfistershammer K, Rieger A, et al. Impact of early initiation of antiretroviral therapy in patients with acute HIV infection in Vienna, Austria. PLoS One. 2016;11(4):e0152910.CrossRef
6.
go back to reference World Health Organization. Scaling up Antiretroviral Therapy in Resource-Limited Settings: Guidelines for a Public Health Approach. Geneva: WHO; 2002. World Health Organization. Scaling up Antiretroviral Therapy in Resource-Limited Settings: Guidelines for a Public Health Approach. Geneva: WHO; 2002.
7.
go back to reference World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach: 2010 Revision. Geneva: WHO; 2010. World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach: 2010 Revision. Geneva: WHO; 2010.
8.
go back to reference World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva: WHO; 2013. World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva: WHO; 2013.
9.
go back to reference World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva: WHO; 2016. World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva: WHO; 2016.
10.
go back to reference World Health Organization. Policy Brief: Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Whats New? Geneva: WHO; 2015. World Health Organization. Policy Brief: Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Whats New? Geneva: WHO; 2015.
11.
go back to reference UNAIDS. 90–90–90: An Ambitious Treatment Target to Help End the AIDS Epidemic. Geneva: UNAIDS; 2014. UNAIDS. 90–90–90: An Ambitious Treatment Target to Help End the AIDS Epidemic. Geneva: UNAIDS; 2014.
12.
go back to reference Guidelines for Antiretroviral Therapy in Zimbabwe. Harare: National Medicine and Therapeutics Policy Advisory Committee and the AIDS and TB Unit; 2010. Guidelines for Antiretroviral Therapy in Zimbabwe. Harare: National Medicine and Therapeutics Policy Advisory Committee and the AIDS and TB Unit; 2010.
13.
go back to reference Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe. Harare: Zimbabwe Ministry of Health and Child Care; 2013. Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe. Harare: Zimbabwe Ministry of Health and Child Care; 2013.
14.
go back to reference Church K, Kiweewa F, Dasgupta A, Mwangome M, Mpandaguta E, Gómez-Olivé FX, et al. A comparative analysis of national HIV policies in six African countries with generalized epidemics. Bull World Health Organ. 2015;93(7):457–67.CrossRef Church K, Kiweewa F, Dasgupta A, Mwangome M, Mpandaguta E, Gómez-Olivé FX, et al. A comparative analysis of national HIV policies in six African countries with generalized epidemics. Bull World Health Organ. 2015;93(7):457–67.CrossRef
15.
go back to reference Assefa Y, Alebachew A, Lera M, Lynen L, Wouters E, Van Damme W. Scaling up antiretroviral treatment and improving patient retention in care: lessons from Ethiopia, 2005–2013. Glob Health. 2014;10:43.CrossRef Assefa Y, Alebachew A, Lera M, Lynen L, Wouters E, Van Damme W. Scaling up antiretroviral treatment and improving patient retention in care: lessons from Ethiopia, 2005–2013. Glob Health. 2014;10:43.CrossRef
16.
go back to reference Schneider H, Coetzee D, Van Rensburg D, Gilson L. Differences in antiretroviral scale up in three South African provinces: the role of implementation management. BMC Health Serv Res. 2010;10(Suppl 1):S4.CrossRef Schneider H, Coetzee D, Van Rensburg D, Gilson L. Differences in antiretroviral scale up in three South African provinces: the role of implementation management. BMC Health Serv Res. 2010;10(Suppl 1):S4.CrossRef
17.
go back to reference World Health Organization. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Geneva: WHO; 2007. World Health Organization. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Geneva: WHO; 2007.
18.
go back to reference Ojikutu B, Makadzange AT, Gaolathe T. Scaling up ART treatment capacity: lessons learned from South Africa, Zimbabwe, and Botswana. Curr HIV/AIDS Rep. 2008;5(2):94–8.CrossRef Ojikutu B, Makadzange AT, Gaolathe T. Scaling up ART treatment capacity: lessons learned from South Africa, Zimbabwe, and Botswana. Curr HIV/AIDS Rep. 2008;5(2):94–8.CrossRef
19.
go back to reference Agaba PA, Meloni ST, Sule HM, Agbaji OO, Ekeh PN, Job GC, et al. Patients who present late to HIV care and associated risk factors in Nigeria. HIV Med. 2014;15(7):396–405.CrossRef Agaba PA, Meloni ST, Sule HM, Agbaji OO, Ekeh PN, Job GC, et al. Patients who present late to HIV care and associated risk factors in Nigeria. HIV Med. 2014;15(7):396–405.CrossRef
20.
go back to reference Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Tropical Med Int Health. 2012;17(12):1509–20.CrossRef Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Tropical Med Int Health. 2012;17(12):1509–20.CrossRef
21.
go back to reference Johnson DC, Feldacker C, Tweya H, Phiri S, Hosseinipour MC. Factors associated with timely initiation of antiretroviral therapy in two HIV clinics in Lilongwe, Malawi. Int J STD AIDS. 2013;24(1):42–9.CrossRef Johnson DC, Feldacker C, Tweya H, Phiri S, Hosseinipour MC. Factors associated with timely initiation of antiretroviral therapy in two HIV clinics in Lilongwe, Malawi. Int J STD AIDS. 2013;24(1):42–9.CrossRef
22.
go back to reference Posse M, Baltussen R. Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care STDs. 2009;23(10):867–75.CrossRef Posse M, Baltussen R. Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care STDs. 2009;23(10):867–75.CrossRef
23.
go back to reference Ndawinz JD, Chaix B, Koulla-Shiro S, Delaporte E, Okouda B, Abanda A, et al. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis. J Antimicrob Chemother. 2013;68(6):1388–99.CrossRef Ndawinz JD, Chaix B, Koulla-Shiro S, Delaporte E, Okouda B, Abanda A, et al. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis. J Antimicrob Chemother. 2013;68(6):1388–99.CrossRef
24.
go back to reference Zimbabwe’s Experience in the Adaptation of the ‘2013 World Health Organization Consolidated Guidelines on the use of Antiretrovirals’ and Status of its Implementation in the Country. Harare: Zimbabwe Ministry of Health and Child Care; 2015. Zimbabwe’s Experience in the Adaptation of the ‘2013 World Health Organization Consolidated Guidelines on the use of Antiretrovirals’ and Status of its Implementation in the Country. Harare: Zimbabwe Ministry of Health and Child Care; 2015.
25.
go back to reference Halperin DT, Mugurungi O, Hallett TB, Muchini B, Campbell B, Magure T, et al. A surprising prevention success: why did the HIV epidemic decline in Zimbabwe? PLoS Med. 2011;8(2):e1000414.CrossRef Halperin DT, Mugurungi O, Hallett TB, Muchini B, Campbell B, Magure T, et al. A surprising prevention success: why did the HIV epidemic decline in Zimbabwe? PLoS Med. 2011;8(2):e1000414.CrossRef
26.
go back to reference Gregson S, Garnett GP, Nyamukapa CA, Hallett TB, Lewis JJ, Mason PR, et al. HIV decline associated with behavior change in Eastern Zimbabwe. Science. 2006;311(5761):664–6.CrossRef Gregson S, Garnett GP, Nyamukapa CA, Hallett TB, Lewis JJ, Mason PR, et al. HIV decline associated with behavior change in Eastern Zimbabwe. Science. 2006;311(5761):664–6.CrossRef
28.
go back to reference Global AIDS Response Progress Report 2016: Zimbabwe Country Report. Harare: Ministry of Health and Child Care; 2016. Global AIDS Response Progress Report 2016: Zimbabwe Country Report. Harare: Ministry of Health and Child Care; 2016.
29.
go back to reference Zimbabwe HIV Care and Treatment Strategic Plan 2013–2017 and Three Year Operational Plan Towards Achievement of Universal Access to Quality HIV Care and Treatment Services. Harare: Zimbabwe Ministry of Health and Child Care; 2013. Zimbabwe HIV Care and Treatment Strategic Plan 2013–2017 and Three Year Operational Plan Towards Achievement of Universal Access to Quality HIV Care and Treatment Services. Harare: Zimbabwe Ministry of Health and Child Care; 2013.
32.
go back to reference National HIV Testing and Counselling Training Course for Health Workers. Harare: Zimbabwe Ministry of Health and Child Care; 2007. National HIV Testing and Counselling Training Course for Health Workers. Harare: Zimbabwe Ministry of Health and Child Care; 2007.
33.
go back to reference Zimbabwe National Guidelines on HIV Testing and Counselling. Harare: Zimbabwe Ministry of Health and Child Care; 2005. Zimbabwe National Guidelines on HIV Testing and Counselling. Harare: Zimbabwe Ministry of Health and Child Care; 2005.
34.
go back to reference Prevention of Mother to Child Transmission. 2nd ed. Harare: Minsirty of Health and Child Care; 2011. Prevention of Mother to Child Transmission. 2nd ed. Harare: Minsirty of Health and Child Care; 2011.
35.
go back to reference National Community and Home Based Care Guidelines. Harare: Zimbabwe Ministry of Health and Child Care; 2009. National Community and Home Based Care Guidelines. Harare: Zimbabwe Ministry of Health and Child Care; 2009.
36.
go back to reference National Community and Home Based Care Guidelines. Harare: Zimbabwe Ministry of Health and Child Care; 2011. National Community and Home Based Care Guidelines. Harare: Zimbabwe Ministry of Health and Child Care; 2011.
37.
go back to reference Patient OI/ART Care Booklet. October 2012 ed. Harare: Zimbabwe Ministry of Health and Child Care; 2012. Patient OI/ART Care Booklet. October 2012 ed. Harare: Zimbabwe Ministry of Health and Child Care; 2012.
38.
go back to reference Zimbabwe National TB Guidelines. 4th ed. Harare: Zimbabwe Ministry of Health and Child Care; 2010. Zimbabwe National TB Guidelines. 4th ed. Harare: Zimbabwe Ministry of Health and Child Care; 2010.
39.
go back to reference 6th Essential Medicines List and Standard Treatment Guidelines for Zimbabwe. Harare: The National Medicine and Therapeutics Policy Advisory Committee [NMTPAC] and Zimbabwe Ministry of Health and Child Welfare; 2011. 6th Essential Medicines List and Standard Treatment Guidelines for Zimbabwe. Harare: The National Medicine and Therapeutics Policy Advisory Committee [NMTPAC] and Zimbabwe Ministry of Health and Child Welfare; 2011.
40.
go back to reference Chronic HIV Care Pre-ART Register. Harare: Zimbabwe Ministry of Health and Child Care; 2012. Chronic HIV Care Pre-ART Register. Harare: Zimbabwe Ministry of Health and Child Care; 2012.
41.
go back to reference Zimbabwe National Guidelines on HIV Testing and Counselling. 2nd ed. Harare: Zimbabwe Ministry of Health and Child Care; 2014. Zimbabwe National Guidelines on HIV Testing and Counselling. 2nd ed. Harare: Zimbabwe Ministry of Health and Child Care; 2014.
42.
go back to reference Integrated Management of Adolescent and Adult Illnesses. Harare: Zimbabwe Ministry of Health and Child Care; 2011. Integrated Management of Adolescent and Adult Illnesses. Harare: Zimbabwe Ministry of Health and Child Care; 2011.
43.
go back to reference Zimbabwe Operational and Service Delivery Manual. Harare: Zimbabwe Ministry of Health and Child Care; 2014. Zimbabwe Operational and Service Delivery Manual. Harare: Zimbabwe Ministry of Health and Child Care; 2014.
44.
go back to reference Guidelines for the Decentralization of OI/ART services. Harare: Zimbabwe Ministry of Health and Child Care; 2011. Guidelines for the Decentralization of OI/ART services. Harare: Zimbabwe Ministry of Health and Child Care; 2011.
45.
go back to reference World Health Organization. Operations Manual for Delivery of HIV Prevention, Care and Treatment at Primary Health Centres in High-prevalence, Resource-constrained Settings. Geneva: WHO; 2008. World Health Organization. Operations Manual for Delivery of HIV Prevention, Care and Treatment at Primary Health Centres in High-prevalence, Resource-constrained Settings. Geneva: WHO; 2008.
46.
go back to reference Zimbabwe National HIV and AIDS Strategic Plan (ZNASP II) 2011–2015. Harare: Ministry of Health and Child Care, Zimbabwe; 2011. Zimbabwe National HIV and AIDS Strategic Plan (ZNASP II) 2011–2015. Harare: Ministry of Health and Child Care, Zimbabwe; 2011.
47.
go back to reference Zimbabwe Population Census 2012. Harare: Zimbabwe National Statistics Agency; 2012. Zimbabwe Population Census 2012. Harare: Zimbabwe National Statistics Agency; 2012.
48.
go back to reference Mungati M, Mhangara M, Dzangare J, Mugurungi O, Apollo T, Gonese E, et al. Results from implementing updated 2012 World Health Organization Guidance on early-warning indicators of HIV drug resistance in Zimbabwe. J Epidemiol Res. 2016;2(2):85–91.CrossRef Mungati M, Mhangara M, Dzangare J, Mugurungi O, Apollo T, Gonese E, et al. Results from implementing updated 2012 World Health Organization Guidance on early-warning indicators of HIV drug resistance in Zimbabwe. J Epidemiol Res. 2016;2(2):85–91.CrossRef
49.
go back to reference Rhead R, Maswera R, Takaruza A, Nyamukapa C, Gregson S, editors. Does sexual risk behaviour vary across the HIV treatment Cascade in East Zimbabwe? Cape Town: The 28th International Population Conference; 2017. Rhead R, Maswera R, Takaruza A, Nyamukapa C, Gregson S, editors. Does sexual risk behaviour vary across the HIV treatment Cascade in East Zimbabwe? Cape Town: The 28th International Population Conference; 2017.
50.
go back to reference Sithole A. Results based financing in Zimbabwe: any changes in the health delivery system? J Soc Welf Hum Rights. 2013;1(1):10. Sithole A. Results based financing in Zimbabwe: any changes in the health delivery system? J Soc Welf Hum Rights. 2013;1(1):10.
51.
go back to reference van de Looij F, Mureyi D, Sisimayi C, Koot J, Manangazira P. Early Evidence from Results-based Financing in Rural Zimbabwe. African Health Monitor. 2015. van de Looij F, Mureyi D, Sisimayi C, Koot J, Manangazira P. Early Evidence from Results-based Financing in Rural Zimbabwe. African Health Monitor. 2015.
52.
go back to reference Bhat N, Kilmarx PH, Dube F, Manenji A, Dube M, Magure T. Zimbabwe’s national AIDS levy: a case study. SAHARA J. 2016;13:1–7.CrossRef Bhat N, Kilmarx PH, Dube F, Manenji A, Dube M, Magure T. Zimbabwe’s national AIDS levy: a case study. SAHARA J. 2016;13:1–7.CrossRef
53.
go back to reference McRobie E, Wringe A, Nakiyingi-Miiro J, Kiweewa F, Lutalo T, Nakigozi G, et al. HIV policy implementation in two health and demographic surveillance sites in Uganda: findings from a national policy review, health facility surveys and key informant interviews. Implementat Sci. 2017;12(1):47.CrossRef McRobie E, Wringe A, Nakiyingi-Miiro J, Kiweewa F, Lutalo T, Nakigozi G, et al. HIV policy implementation in two health and demographic surveillance sites in Uganda: findings from a national policy review, health facility surveys and key informant interviews. Implementat Sci. 2017;12(1):47.CrossRef
54.
go back to reference Dasgupta AN, Wringe A, Crampin AC, Chisambo C, Koole O, Makombe S, et al. HIV policy and implementation: a national policy review and an implementation case study of a rural area of northern Malawi. AIDS Care. 2016;28(9):1097–109.CrossRef Dasgupta AN, Wringe A, Crampin AC, Chisambo C, Koole O, Makombe S, et al. HIV policy and implementation: a national policy review and an implementation case study of a rural area of northern Malawi. AIDS Care. 2016;28(9):1097–109.CrossRef
55.
go back to reference Piffaretti NF. Zimbabwe – Economic Policy Dialogue: Policy Notes for the New Government, 2013. Washington: World Bank Group; 2014. Piffaretti NF. Zimbabwe – Economic Policy Dialogue: Policy Notes for the New Government, 2013. Washington: World Bank Group; 2014.
56.
go back to reference Ambia J, Renju J, Wringe A, Todd J, Geubbels E, Nakiyingi-Miiro J, et al. From policy to practice: exploring the implementation of antiretroviral therapy access and retention policies between 2013 and 2016 in six sub-Saharan African countries. BMC Health Serv Res. 2017;17(1):758.CrossRef Ambia J, Renju J, Wringe A, Todd J, Geubbels E, Nakiyingi-Miiro J, et al. From policy to practice: exploring the implementation of antiretroviral therapy access and retention policies between 2013 and 2016 in six sub-Saharan African countries. BMC Health Serv Res. 2017;17(1):758.CrossRef
57.
go back to reference Hansen K, Woelk G, Jackson H, Kerkhoven R, Manjonjori N, Maramba P, et al. The cost of home-based care for HIV/AIDS patients in Zimbabwe. AIDS Care. 1998;10(6):751–9.CrossRef Hansen K, Woelk G, Jackson H, Kerkhoven R, Manjonjori N, Maramba P, et al. The cost of home-based care for HIV/AIDS patients in Zimbabwe. AIDS Care. 1998;10(6):751–9.CrossRef
59.
go back to reference Spyrelis A, Abdulla S, Frade S, Meyer T, Mhazo M, Taruberekera N, et al. Are women more likely to self-test? A short report from an acceptability study of the HIV self-testing kit in South Africa. AIDS Care. 2017;29(3):339–43.CrossRef Spyrelis A, Abdulla S, Frade S, Meyer T, Mhazo M, Taruberekera N, et al. Are women more likely to self-test? A short report from an acceptability study of the HIV self-testing kit in South Africa. AIDS Care. 2017;29(3):339–43.CrossRef
60.
go back to reference Lecher S, Ellenberger D, Kim AA, Fonjungo PN, Agolory S, Borget MY, et al. Scale-up of HIV viral load monitoring--seven sub-Saharan African countries. MMWR Morb Mortal Wkly Rep. 2015;64(46):1287–90.CrossRef Lecher S, Ellenberger D, Kim AA, Fonjungo PN, Agolory S, Borget MY, et al. Scale-up of HIV viral load monitoring--seven sub-Saharan African countries. MMWR Morb Mortal Wkly Rep. 2015;64(46):1287–90.CrossRef
61.
go back to reference Alemnji G, Onyebujoh P, Nkengasong JN. Improving laboratory efficiencies to scale-up HIV viral load testing. Curr Opin HIV AIDS. 2017;12(2):165–70.CrossRef Alemnji G, Onyebujoh P, Nkengasong JN. Improving laboratory efficiencies to scale-up HIV viral load testing. Curr Opin HIV AIDS. 2017;12(2):165–70.CrossRef
62.
go back to reference DART Trial Team. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet. 2010;375(9709):123–31. DART Trial Team. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet. 2010;375(9709):123–31.
63.
go back to reference Zimbabwe Population-Based HIV Impact Assessment (ZIMPHIA) 2015-2016. Harare: Zimbabwe Ministry of Health and Child Care; 2017. Zimbabwe Population-Based HIV Impact Assessment (ZIMPHIA) 2015-2016. Harare: Zimbabwe Ministry of Health and Child Care; 2017.
Metadata
Title
A longitudinal review of national HIV policy and progress made in health facility implementation in Eastern Zimbabwe
Authors
Malebogo Tlhajoane
Tidings Masoka
Edith Mpandaguta
Rebecca Rhead
Kathryn Church
Alison Wringe
Noah Kadzura
Nimalan Arinaminpathy
Constance Nyamukapa
Nadine Schur
Owen Mugurungi
Morten Skovdal
Jeffrey W. Eaton
Simon Gregson
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Health Research Policy and Systems / Issue 1/2018
Electronic ISSN: 1478-4505
DOI
https://doi.org/10.1186/s12961-018-0358-1

Other articles of this Issue 1/2018

Health Research Policy and Systems 1/2018 Go to the issue